401 related articles for article (PubMed ID: 1618603)
41. Discriminatory effect of anti-Pr-beta-hCG-TT antibodies on the neutralization of the biological activity of placental and pituitary gonadotropins.
Das C; Talwar GP; Ramakrishnan S; Salahuddin M; Kumar S; Hingorani V; Coutinho E; Croxatto H; Hemmingson E; Johansson E; Luukkainen T; Shahani S; Sundaram K; Nash H; Segal SJ
Contraception; 1978 Jul; 18(1):35-50. PubMed ID: 98287
[TBL] [Abstract][Full Text] [Related]
42. Developments in the control of testicular function.
Swerdloff RS; Wang C; Bhasin S
Baillieres Clin Endocrinol Metab; 1992 Apr; 6(2):451-83. PubMed ID: 1377467
[TBL] [Abstract][Full Text] [Related]
43. Development of immunological methods of fertility regulation.
Spieler J
Bull World Health Organ; 1987; 65(6):779-83. PubMed ID: 3124969
[TBL] [Abstract][Full Text] [Related]
44. A vaccine that prevents pregnancy in women.
Talwar GP; Singh O; Pal R; Chatterjee N; Sahai P; Dhall K; Kaur J; Das SK; Suri S; Buckshee K
Proc Natl Acad Sci U S A; 1994 Aug; 91(18):8532-6. PubMed ID: 8078917
[TBL] [Abstract][Full Text] [Related]
45. Histological study of the draining lymph nodes after injection of antigen and adjuvant materials tried for fertility control.
Nasr EM; El-mekkawi M; Moussa MA; Ahmed AA
Popul Sci; 1981; (2):137-48. PubMed ID: 12339479
[TBL] [Abstract][Full Text] [Related]
46. Birth control vaccines and immunological approaches to the therapy of noninfectious diseases.
Stevens VC
Infect Dis Clin North Am; 1990 Jun; 4(2):343-54. PubMed ID: 2345290
[TBL] [Abstract][Full Text] [Related]
47. Immunological cross-reactivity of antibodies with species chorionic gonadotropin is a critical requirement for efficacy testing of human gonadotropin vaccines in sub-human primates.
Rao LV; Singh O; Talwar GP
J Reprod Immunol; 1988 Jun; 13(1):53-63. PubMed ID: 3418617
[TBL] [Abstract][Full Text] [Related]
48. Use of hCG stimulation test in women immunized with beta-hCG vaccine.
Shahani SM; Patel KL
Contraception; 1991 Oct; 44(4):453-60. PubMed ID: 1756630
[TBL] [Abstract][Full Text] [Related]
49. Reversible inhibition of testicular function by a gonadotropin hormone-releasing hormone antagonist in monkeys (Macaca fascicularis).
Weinbauer GF; Surmann FJ; Akhtar FB; Shah GV; Vickery BH; Nieschlag E
Fertil Steril; 1984 Dec; 42(6):906-14. PubMed ID: 6389185
[TBL] [Abstract][Full Text] [Related]
50. Potential of testosterone buciclate for male contraception: endocrine differences between responders and nonresponders.
Behre HM; Baus S; Kliesch S; Keck C; Simoni M; Nieschlag E
J Clin Endocrinol Metab; 1995 Aug; 80(8):2394-403. PubMed ID: 7543113
[TBL] [Abstract][Full Text] [Related]
51. How far from a hormone-based contraceptive vaccine?
Delves PJ
J Reprod Immunol; 2004 Jun; 62(1-2):69-78. PubMed ID: 15288183
[TBL] [Abstract][Full Text] [Related]
52. GnRH analogues for contraception.
Fraser HM
Br Med Bull; 1993 Jan; 49(1):62-72. PubMed ID: 8324616
[TBL] [Abstract][Full Text] [Related]
53. Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion.
Marrs RP; Kletzky OA; Howard WF; Mishell DR
Am J Obstet Gynecol; 1979 Nov; 135(6):731-6. PubMed ID: 495673
[TBL] [Abstract][Full Text] [Related]
54. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.
Tom L; Bhasin S; Salameh W; Steiner B; Peterson M; Sokol RZ; Rivier J; Vale W; Swerdloff RS
J Clin Endocrinol Metab; 1992 Aug; 75(2):476-83. PubMed ID: 1639948
[TBL] [Abstract][Full Text] [Related]
55. Antibody response to Pr-beta-HCG-TT vaccine in human subjects.
Talwar GP; Dubey SK; Salahuddin M; Das C
Contraception; 1976 Feb; 13(2):237-43. PubMed ID: 1245129
[TBL] [Abstract][Full Text] [Related]
56. Contraceptive vaccine development.
Alexander NJ; Bialy G
Reprod Fertil Dev; 1994; 6(3):273-80. PubMed ID: 7831480
[TBL] [Abstract][Full Text] [Related]
57. Immunocontraceptive Effects in Male Rats Vaccinated with Gonadotropin-Releasing Hormone-I and -II Protein Complex.
Kim YH; Park BJ; Ahn HS; Han SH; Go HJ; Lee JB; Park SY; Song CS; Lee SW; Choi IS
J Microbiol Biotechnol; 2019 Apr; 29(4):658-664. PubMed ID: 30845792
[TBL] [Abstract][Full Text] [Related]
58. Whither an anti-hCG approach for the control of fertility.
Res Reprod; 1981 Jul; 13(3):1-2. PubMed ID: 12263408
[TBL] [Abstract][Full Text] [Related]
59. Vaccines and passive immunological approaches for the control of fertility and hormone-dependent cancers.
Talwar GP
Immunol Rev; 1999 Oct; 171():173-92. PubMed ID: 10582171
[TBL] [Abstract][Full Text] [Related]
60. Antipregnancy vaccine.
Cohen J
Contracept Fertil Sex (Paris); 1976 Oct; 4(6):399-400. PubMed ID: 12334581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
